The Three-Year Outcome Of Infliximab (Ifx), An Anti-Tnf-Alpha Antibody, In Patients With Refractory Intestinal-Behcet'S Disease (Bd)

ANNALS OF THE RHEUMATIC DISEASES(2014)

引用 2|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要